Process for preparation of substituted nicotinamides
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI SIMR BIOTECHNOLOGY CO LTD
- Publication Date
- 2022-07-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to N-isopropyl-6-(((3-(5-(methoxymethyl)isoxazol-3-yl)-[1,2,4]triazo[3,4-a] ] phthalazin-6-yl) oxy) methyl) nicotinamide synthesis process. Background technique
[0002] N-isopropyl-6-(((3-(5-(methoxymethyl)isoxazol-3-yl)-[1,2,4]triazolo[3,4-a]phthalazine -6-yl)oxy)methyl)nicotinamide is an antagonist of the α5-GABAA receptor and is described in Chinese patent application CN2019101857359.
[0003] Antagonists of α5-GABAA receptors were recently identified as useful in the treatment of pain, particularly neuropathic pain (WO), and N-isopropyl-6-(((3-(5-(methoxymethyl) Isoxazol-3-yl)-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)oxy)methyl)nicotinamide was identified as a candidate drug whose structure is shown in formula (1 ) as shown:
[0004]
[0005] For the preparation of N-isopropyl-6-(((3-(5-(methoxymethyl)isoxazol-3-yl)-[1,2,4]triazole[3 in the prior art ,4-a]phthalazin-6-yl)oxy)methyl)nicotinamide method has low yie...